MedPath
NMPA Approval

Erlotinib Hydrochloride Tablets

国药准字HJ20240114

October 22, 2024

Drug Information

盐酸厄洛替尼片

片剂

100mg(按C₂₂H₂₃N₃O₄计)

化学药品

October 22, 2024

October 21, 2029

Company Information

Applicant Company

Formulation Unit -VII, Plot Nos. P1 to P9, Phase-III, VSEZ, Duvvada, Visakhapatnam District 530046, Andhra Pradesh, India.

Manufacturing Company

Formulation Unit -VII, Plot Nos. P1 to P9, Phase-III, VSEZ, Duvvada, Visakhapatnam District 530046, Andhra Pradesh, India.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.